Skip to main content

Illumina Inc(ILMN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Illumina's Board of Directors elects two experienced Independent Directors to Board

PR Newswire - Fri Jun 2, 6:30AM CDT

Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina's Board

Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board

SAN DIEGO, June 2, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).